Thiotepa fda label
WebOnly one thiotepa drug product (ANDA 075547) is currently available and is listed as the reference drug. Thiotepa (ANDA 075547) is marketed as single use vials containing 15 … WebU.S. Food and Drug Administration
Thiotepa fda label
Did you know?
WebThe packaging for TEPADINA® differs from the FDA approved labeling for Thiotepa for Injection, USP supplied by Bedford. TEPADINA® has no bar code or NDC number. … Web• Thiotepa 5 mg/kg twice a day, given as two intravenous infusions over 2–4 hours on day -2 before stem cell infusion (day 0). Elderly No dose adjustment is necessary in any subset of the elderly population. Renal and hepatic impairment No dose adjustment is necessary for mild or moderate impairment, but treosulfan is contraindicated in
WebDrugBank Accession Number. DB04572. Background. N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years. It is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. WebApr 30, 2012 · guide to therapy with this drug. In general, the larger the dose employed, the more profound and longer lasting the leukopenia will be. The fact that the white-blood-cell count returns to normal levels after drug-induced leukopenia is an indication that the white-cell-producing mechanism is not permanently depressed.
WebThe NDC Code 0143-9565-01 is assigned to “Thiotepa ” (also known as: “Thiotepa”), a human prescription drug labeled by “Hikma Pharmaceuticals USA Inc.”. The product's dosage form is injection, powder, lyophilized, for solution, and is administered via intracavitary; intravenous; intravesical form. WebThiotepa is a cytotoxic anticancer drug and as with other potentially toxic compounds, caution should be exercised in handling and preparation of thiotepa. ... Vial Label. Thiotepa for Injection, USP vial label image. NDC 0143-9309-01. Thiotepa for Injection, USP. 15 mg/vial. For Intravenous, Intracavitary, or Intravesical. SERIALIZATION IMAGE.
WebSep 21, 2024 · Thiotepa side effects. Get emergency medical help if you have signs of an allergic reaction: hives; wheezing, difficult breathing; swelling of your face, lips, tongue, or throat.. Thiotepa may cause serious side effects. Call your doctor at once if you have: sores or white patches in or around your mouth, trouble swallowing or talking, dry mouth, bad …
WebTitle: 75-547 Thiotepa Final Print Label Created Date: 12/5/2001 10:47:52 AM university of maryland crna 2021Web7 DRUG. 7.1 UGT1A1 Inhibitors or Inducers . 8 USE IN SPECIFIC POPULATIONS . 8.1 Pregnancy . 8.2 Lactation . 8.3 Females and Males of Reproductive Potential . 8.4 … university of maryland culinary artsWebAdvise the patient to read the FDA-approved patient labeling (Patient Information). Cardiomyopathy Advise patients that Doxorubicin Hydrochloride Injection/for Injection can cause irreversible myocardial damage and to contact a healthcare provider for symptoms of heart failure during or after treatment [see Warnings and Precautions (5.1) ] . university of maryland cufflinksWebGeneral information. Class/mechanism: Alkylator, ethylenimine-type, similar to nitrogen mustards. Ethylenimine radicals are released, which alkylates at the N7 position of guanine, resulting in the linkage between the purine and sugar being severed, and subsequent cell damage and death. [1] [2] Route: IV, intravesicular, intracavitary; (off ... university of maryland cssaWebCheck all prescription and nonprescription medicine labels carefully since many contain pain relievers/fever reducers ... FDA Labeling for thiotepa vial on RxList; Latest Drug News; Find a Pharmacy; reason unscrambledWebDoxorubicin ThioTEPA Note: Use special procedures and precautions when working with volatile chemotherapy drugs. For more information and guidance, contact an EH&S occupational health and safety specialist at [email protected] or 206-543-7388, or contact the agent manufacturer. Back to top IV. PERSONAL PROTECTIVE EQUIPMENT (PPE) 1. university of maryland crna schoolWebFeb 6, 2024 · Prior to intravesical administration, patients should be dehydrated for 8–12 hours. Instill 60 mL of diluted thiotepa solution by catheter into the bladder; retain solution … reason\u0027s swiss cheese model powerpoint